Johnson & Johnson Public Float
Johnson & Johnson (JNJ) had Public Float of $367.00 billion as of 2025-06-29, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-11
- 2025-06-29: Entity Public Float $367.00B.
- 2024-06-30: Entity Public Float $352.00B.
- 2023-07-02: Entity Public Float $430.00B.
- 2022-07-03: Entity Public Float $472.00B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-29 | $367.00B 10-K · filed 2026-02-11 | |
| 2024-06-30 | $352.00B 10-K · filed 2025-02-13 | |
| 2023-07-02 | $430.00B 10-K · filed 2024-02-16 | |
| 2022-07-03 | $472.00B 10-K · filed 2023-02-16 | |
| 2021-07-04 | $445.00B 10-K · filed 2022-02-17 | |
| 2020-06-28 | $363.00B 10-K · filed 2021-02-22 | |
| 2019-06-30 | $368.00B 10-K · filed 2020-02-18 | |
| 2018-07-01 | $325.00B 10-K · filed 2019-02-20 | |
| 2017-07-02 | $332.00B 10-K · filed 2018-02-21 | |
| 2016-07-03 | $332.00B 10-K · filed 2017-02-27 | |
| 2015-06-28 | $276.00B 10-K · filed 2016-02-24 | |
| 2014-06-29 | $296.00B 10-K · filed 2015-02-24 | |
| 2013-06-28 | $242.00B 10-K · filed 2014-02-21 | |
| 2012-07-01 | $186.00B 10-K · filed 2013-02-22 | |
| 2011-07-03 | $184.00B 10-K · filed 2012-02-23 | |
| 2010-07-04 | $163.00B 10-Q · filed 2011-11-08 | $162.93B 10-K · filed 2011-02-25 |
| 2009-06-28 | $156.00B 10-K · filed 2010-03-01 | $155.90B 10-Q · filed 2009-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |